Cargando…
Efficacy, safety, and pharmacokinetics of teduglutide in adult Japanese patients with short bowel syndrome and intestinal failure: two phase III studies with an extension
PURPOSE: The short- and long-term efficacy, safety, and pharmacokinetics of teduglutide were analyzed in adult Japanese patients with short bowel syndrome and intestinal failure (SBS-IF). METHODS: Patients received teduglutide 0.05 mg/kg/day in clinical trials (TED-C14-004, SHP633-306, and extension...
Autores principales: | Nakamura, Shiro, Wada, Motoshi, Mizushima, Tsunekazu, Sugita, Akira, Tazuke, Yuko, Ohge, Hiroki, Udagawa, Eri, Suzuki, Ryohsuke Ken, Yoon, MinJung, Grimm, Andrew, Chen, Szu-Ta, Ikeuchi, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950205/ https://www.ncbi.nlm.nih.gov/pubmed/36201060 http://dx.doi.org/10.1007/s00595-022-02587-4 |
Ejemplares similares
-
Etiologies and treatments of chronic intestinal failure-short bowel syndrome (SBS) in Japanese adults: a real-world observational study
por: Mizushima, Tsunekazu, et al.
Publicado: (2022) -
Real‐world etiologies and treatments of pediatric short bowel syndrome in Japan
por: Tazuke, Yuko, et al.
Publicado: (2022) -
Efficacy and Safety of Teduglutide in Infants and Children With Short Bowel Syndrome Dependent on Parenteral Support
por: Chiba, Masahiro, et al.
Publicado: (2023) -
Teduglutide for short bowel syndrome
Publicado: (2020) -
Teduglutide in amyloidosis‐associated intestinal failure
por: Luhn, Clara, et al.
Publicado: (2023)